Provia™Injectable Gel for Targeted, Slow-Release Delivery
Provia™ is Likarda’s versatile, injectable polymer gel designed for the slow release of biologics, small molecules, or diagnostic agents directly at the site of action. Unlike microbead formats, Provia™ does not require our Core-Shell Spherification® (CSS®) instrument to produce, making it an off-the-shelf solution for rapid deployment.
How It Works
Once injected, Provia™ forms a localized depot that gradually releases its payload over time. This sustained release helps maintain consistent therapeutic levels, reducing the need for frequent dosing and minimizing systemic exposure.
Primary Benefits of Provia™
Targeted Delivery Without the Equipment.
No encapsulation equipment required.
Suitable for both large and small molecules.
Delivers directly to the target tissue or site of interest.
Adjustable formulation to meet specific therapeutic timelines.
Simplifies manufacturing and distribution.
Real-World Applications
Provia™ is ideal for therapies and wellness products where convenience, controlled release, and targeted delivery are essential. Current development programs include peptide-based wellness supplements and site-specific drug delivery.
Peptide Wellness Injection
Under development for a wellness peptide, enabling weekly delivery via a single subcutaneous injection.
Diagnostic & Therapeutic Potential
Useful in pain management, hormone regulation, and immunology where dosing consistency is key.
Streamlined Administration
Simplifies rollout for providers and patients alike.
Explore Other Molecule Delivery Platforms
Compare Provia™ with other technologies designed to optimize dosing, delivery route, and molecule protection.
Let’s Collaborate
Need a fast-track solution for sustained drug delivery? Let’s talk about how Provia™ can simplify and scale your therapeutic strategy.